| CODEXIS INC. DL-,01 |
| USA |
| Gesundheit |
| US1920051067 / A0Q2S4 |
| 4QK (Frankfurt) / CDXS (NASDAQ) |
| FRA:4QK, ETR:4QK, 4QK:GR, NASDAQ:CDXS |
| - |
| http://www.codexis.com/ |
|
Codexis Inc. is a biotechnology company focused on enzyme engineering and biocatalysis. Codexis develops and commercializes proprietary protein engineering technologies that create tailored enzymes for pharmaceutical manufacturing, RNA synthesis, mol..
>Volltext.. |
| 126.89 Mio. EUR |
| 142.03 Mio. EUR |
| 68.19 Mio. EUR |
| -13.69 Mio. EUR |
| -26.97 Mio. EUR |
| -0.3 EUR |
| 63.72 Mio. EUR |
| 24.22 Mio. EUR |
| -9.13 Mio. EUR |
| 2.35 |
| 35.89% |
| 52.72% |
| - |
| - |
| - |
| - |
| CODEXIS |
| 28.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|